AdaptHealth (AHCO) Cash & Current Investments (2017 - 2026)

AdaptHealth has reported Cash & Current Investments for 10 years, with the latest figure at $43.3 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 36.92% year-over-year to $43.3 million in Q2 2026; TTM through Jun 2026 was $43.3 million, a 36.92% decrease from a year earlier, with the FY2025 full-year figure at $106.1 million, down 3.29% from the prior year.
• Cash & Current Investments was $43.3 million for Q2 2026 at AdaptHealth, down from $48.0 million in the prior quarter.
• The five-year high for Cash & Current Investments was $119.4 million in Q1 2022, with the low at $43.3 million in Q2 2026.
• Average Cash & Current Investments over 5 years is $79.7 million, with a median of $78.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments slumped 69.08% in 2022, then jumped 78.44% in 2024.
• Over 5 years, Cash & Current Investments stood at $46.3 million in 2022, then surged by 66.69% to $77.1 million in 2023, then soared by 42.28% to $109.7 million in 2024, then declined by 3.29% to $106.1 million in 2025, then slumped by 59.21% to $43.3 million in 2026.
• The last three Cash & Current Investments figures came in at $43.3 million (Q2 2026), $48.0 million (Q1 2026), and $106.1 million (Q4 2025), per Business Quant data.